1 April 2013 in Parasitology
SUMMARY: In Russia, both alveolar and cystic echinococcoses are endemic. This study aimed to identify the aetiological agents of the diseases and to investigate the distribution of eachEchinococcusspecies in Russia. A total of 75Echinococcusspecimens were collected from 14 host species from 2010 to 2012. Based on the mitochondrial DNA sequences, they were identified asEchinococcus granulosussensu stricto (s.s.),E. canadensisandE. multilocularis. E. granulosuss.s. was confirmed in the European Russia and the Altai region. Three genotypes, G6, G8 and G10 ofE. canadensiswere detected in Yakutia. G6 was also found in the Altai region. Four genotypes ofE. multiloculariswere confirmed; the Asian genotype in the western Siberia and the European Russia, the Mongolian genotype in an island of Baikal Lake and the Altai Republic, the European genotype from a captive monkey in Moscow Zoo and the North American genotype in Yakutia. The present distributional record will become a basis of public health to control echinococcoses in Russia. The rich genetic diversity demonstrates the importance of Russia in investigating the evolutionary history of the genusEchinococcus.
10 January 2022 in Siberian journal of oncology
The purpose of the study was to analyze the cancer incidence in the males born from 1932 to 1949 and living in rural settlements of the municipal districts of the altai Krai affected by the traces from semipalatinsk first nuclear test on august 29, 1949. Material and methods. an epidemiological retrospective cohort study was based on the analysis of anonymized data on newly diagnosed and morphologically verified cases of cancer in a male cohort for the period from 2007 to 2016. the study included a cohort fixed by the date of the first nuclear test with a total of 6383 males. in total, 633 cases were identified in the cohort with newly diagnosed and morphologically verified cancer. at the beginning of the study, all males were alive and had no previous diagnosis of cancer. For a comparative analysis of the cancer incidence, the main (exposed) cohort comprised 2 291 men, and the control cohort included 4 092 men, who lived in rural settlements of municipal districts of the region and were not tracked during the first nuclear test conducted at the semipalatinsk test site. the person-time incidence rate (ptR), standard error (mptR) and confidence intervals (95 % ci) were calculated. the incidence and the relative risk of developing cancer were assessed. statistical analysis was carried out using microsoft office 2016. Results. the number of person-years in the main cohort was 1 6731 person-years, and in the control was 30 747. The incidence rate of person-time (ptR) in the main cohort was 2 032.22 × 105 person-years, with mptR equal to 110.21 and confidence intervals (95 % ci) – (1 811.80–2 252.64). in the control cohort, the corresponding values were: ptR – 952.94 × 105 person-years with mptR – 55,67 and 95 % ci (841.60–1 064.28). the most common cancer localizations in men of the main cohort were: digestive organs (c15-c26), respiratory and chest organs (c30-c39), skin (c43-c44), male genitals (c60-c63). in the control group, the most common localizations were respiratory and chest organs (c30-c39), digestive organs (c15-c26), male genital organs (c60-c63) and skin (c43-c44). Conclusion. an increased relative risk of developing malignant neoplasms in men born and living in the altai territory during the first nuclear test conducted at the semipalatinsk test site was revealed (RR=2.133; 95 % ci 1.824–2.493) with standard error of relative risk (s) equal to 0.0797. there were differences in cancer localization between the main and the control cohorts.
1 January 2023 in Bulletin of Medical Science
Бюллетень медицинской науки Журнал «Бюллетень медицинской науки» Журнал АГМУ «Бюллетень медицинской науки» — это электронный научно-практический медицинский рецензируемый журнал Алтайского государственного медицинского университета. Журнал публикует оригинальные исследования, описания клинических случаев, научные обзоры и дискуссии.
3 April 2023 in Bulletin physiology and pathology of respiration
Aim. To assess the effect of serum homocysteine levels on treatment outcomes in patients with COVID19-associated lung damage, depending on the use of folic acid in complex treatment.Materials and methods. An open, prospective comparative study included 71 hospitalized adult patients with COVID-19-associated lung disease who did not require mechanical ventilation. The main group included 51 patients who received folic acid 15 mg per day in a complex treatment in a fixed combination with pyridoxine hydrochloride and cyanocobalamin. The comparison group included 20 patients in whose therapy folic acid was not used.Results. The use of folic acid was accompanied by a decrease in serum homocysteine concentration by 2.120 (-0.230; 3.680) µmol/L (p=0.004). When constructing a logistic regression model, the effect of a decrease in serum homocysteine (OR 1.289; 95% CI 1.026‒1.620; p=0.029), methylenetetrahydrofolate reductase MTHFR C677T genotype (OR 10.897; 95% CI 1.240‒95.772; p=0.031) on the achievement of 7th day of hospitalization, the cessation of isolation of SARS-CoV-2 virus RNA from the respiratory tract. Multiple linear regression analysis showed an association between the duration of hypoxemic respiratory failure, determined with SaO2≤93%, with the degree of change in serum homocysteine concentration after treatment, single nucleotide polymorphisms of methylenetetrahydrofolate reductase MTHFR C677T, methionine synthase MTR A2756G and methionine synthase reductase MTRR A66G, initial volume of lung damage ≥50% according to CT data, indicators of D-dimers, C-reactive protein, hemoglobin, platelets, concomitant hypertension, diabetes mellitus (R=0.699; R2=0.489; p=0.005).Conclusion. The dynamics of the decrease in serum homocysteine after treatment is an important predictor of the cessation of isolation from the respiratory tract of the SARS-CoV-2 virus RNA on the 7th day of treatment, reducing the duration of hypoxemic respiratory failure in patients with lung damage associated with COVID-19 infection.
19 March 2023 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
The paper presents clinical observation of a patient with cholelithiasis and so-called “difficult” choledocholithiasis. Considering the developed complications – mechanical jaundice and purulent cholangitis, as well as large operative risk, it was decided to refrain from open surgical intervention. Traditionally-performed endoscopic stone extraction did not provide any success. Contact electro-impulse lithotripsy and lithotomy were performed. This enabled choledocholithiasis and cholangitis to be eliminated, bile ducts patency to be restored, and ensured the possibility of safe elective surgical intervention for chronic calculous cholecystitis.
10 June 2021 in PULMONOLOGIYA
Obstructive sleep apnea (OSA) is a common disease. The incidence is higher in patients with chronic obstructive pulmonary disease with moderate to severe bronchial obstruction or hypoxemia. OSA is associated with increased risks of fatal outcomes of acute cardiovascular diseases in such patients. Objective. To assess the effect of long-term non-invasive ventilation of the lungs in the spontaneous breathing mode with positive airway pressure (CPAP) on the indicators of systemic inflammation, insulin resistance, and thrombogenic risk together with clinical outcomes during the rehabilitation period after an exacerbation in patients with concomitant chronic obstructive pulmonary disease and obstructive sleep apnea who do not need long-term oxygen therapy. Methods. The effects of long-term CPAP therapy as a part of complex treatment were analyzed in an openlabel, prospective, comparative six-week study that enrolled 65 patients with concomitant chronic obstructive pulmonary disease and obstructive sleep apnea. The main group included 26 people who received CPAP therapy as a part of complex treatment. The comparison group included 39 people who did not use non-invasive ventilation of the lungs. The patients’ age was 55.5 ± 2.1 years in the main group and 57.1 ± 1.5 years in the comparison group (p > 0.1). Men prevailed in both groups – 92.3% in the main group and 100.0% in the comparison group (p > 0.1). Results. The clinical efficacy of CPAP therapy was confirmed by an improvement in the quality of life of patients on the SF-36 questionnaire, a decrease in the degree of daytime sleepiness on the Epworth scale (Johns, 1991). CPAP-therapy was associated with a drop in the serum levels of tumor necrosis factor α and the blood level of endothelin 1, a more pronounced decrease in the levels of C-reactive protein, interleukin 8, C-peptide, vascular endothelial growth factor, homocysteine versus the comparison group. Conclusion. The use of CPAP-therapy in patients with concomitant chronic obstructive pulmonary disease and obstructive sleep apnea who do not need long-term oxygen therapy during the rehabilitation period after an exacerbation is associated with a decrease in systemic inflammation, vascular endothelial dysfunction, and hyperhomocysteinemia.